Works matching HER2/neu protein


Results: 86
    1
    2
    3
    4
    5
    6
    8
    9
    10
    11
    12
    13
    14
    15

    P435 HER2/neu-derived peptide conjugated to liposomes containing DOPE as an effective prophylactic vaccine formulation for breast cancer.

    Published in:
    Artificial Cells, Nanomedicine & Biotechnology, 2019, v. 47, n. 1, p. 664, doi. 10.1080/21691401.2019.1576702
    By:
    • Farzad, Niloofar;
    • Barati, Nastaran;
    • Momtazi-Borojeni, Amir Abbas;
    • Yazdani, Mona;
    • Arab, Atefeh;
    • Razazan, Atefeh;
    • Shariat, Sheida;
    • Mansourian, Mercedeh;
    • Abbasi, Azam;
    • Saberi, Zahra;
    • Badiee, Ali;
    • Jalali, Seyed Amir;
    • Jaafari, Mahmoud Reza
    Publication type:
    Article
    16
    17
    18
    19
    20
    21
    22
    23
    24
    25
    26
    27
    28
    29
    30
    31
    32
    33
    34
    35
    36
    37

    Resistance to Trastuzumab.

    Published in:
    Cancers, 2022, v. 14, n. 20, p. 5115, doi. 10.3390/cancers14205115
    By:
    • Vivekanandhan, Sneha;
    • Knutson, Keith L.
    Publication type:
    Article
    38
    39
    40
    41
    42

    HER2/neu antisense targeting of human breast carcinoma.

    Published in:
    Oncogene, 2000, v. 19, n. 53, p. 6138, doi. 10.1038/sj.onc.1204001
    By:
    • Roh, Haeri;
    • Pippin, James A;
    • Green, Douglas W;
    • Boswell, Craig B;
    • Hirose, Christopher T;
    • Mokadam, Nahush;
    • Drebin, Jeffrey A
    Publication type:
    Article
    43
    44
    45
    46

    Sebaceous carcinoma of the breast.

    Published in:
    Pathology International, 2000, v. 50, n. 1, p. 63, doi. 10.1046/j.1440-1827.2000.01003.x
    By:
    • Varga, Zsuzsanna;
    • Kolb, Stefan A.;
    • Flury, Renata;
    • Burkhard, Roger;
    • Caduff, Rosmarie
    Publication type:
    Article
    47
    48
    49
    50